dostarlimab
gsk
['breast', 'i-spy', 'dostarlimab', 'paclitaxel', 'paclitaxel, oral', 'i-spy2', 'bcsm', 'tnbc', 'carboplatin']
among 56 pts in #asco23 i-spy2, combo oral paclitaxel, carboplatin + dostarlimab was found to be safe &amp; moderately effective, demonstrating an estimated pcr rate of 48% in early tnbc: #breastcancer #bcsm #ascodailynews 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.